Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2019
Pharma News, 2019
“MedImmune” brand to be retired as biologics integrate into AstraZeneca’s new R&D structure
February 14, 2019, Gaithersburg, Md.
The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species
Ageing constitutes the most important risk factor for all major chronic ailments, including malignant, cardiovascular and neurodegenerative diseases.
Ireland urges people not to stockpile medicines ahead of Brexit
DUBLIN (Reuters) - Ireland’s deputy prime minister on Tuesday called on people not to stockpile medicine before Britain quits the European Union, saying the country had at least eight weeks ...
Japan approves world-first trial using iPS cells to treat spinal cord injuries
The health ministry on Monday approved the world’s first clinical test in which artificially derived stem cells will be used to treat patients with spinal cord injuries.
Intercept Announces Positive Topline Results from Pivotal Phase 3 REGENERATE Study of Obeticholic Acid in Patients with Liver Fibrosis Due to NASH
NEW YORK, Feb.
Experimental Anti-Aging Treatment That Kills Old Cells Has Passed First Human Trial
Not all damaged cells die.
Physicists pinpoint a simple mechanism that makes bacteria resistant to antibiotics
Physicists at McMaster University have for the first time identified a simple mechanism used by potentially deadly bacteria to fend off antibiotics, a discovery which is providing new insights into ho...
Neuromelanin-sensitive MRI identified as a potential biomarker for psychosis
NIH-funded study found Neuromelanin-sensitive MRI able to measure dopamine function associated with psychosisResearchers have shown that a type of magnetic resonance imaging -- called neuromelanin-sen...
Innovate UK awards AKLRD £675,000 for osteoarthritis drug
AKL Research and Development’s (AKLRD) early-stage osteoarthritis drug has won a prestigious award from Innovate UK, as a potential “game-changing” treatment.
Darolutamide shows promise for treatment of prostate cancer
Orion's and Bayer's darolutamide has shown substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial.
Lundbeck and Otsuka report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder
Valby, Denmark and Tokyo, Japan, 14 February 2019 -- H.
Experimental 'nano-painkiller' is more effective than morphine but has low addiction risk, scientists discover
Driven by opioid addictions, more than 70,000 Americns died of drug overdoses in 2017.
50
51
52
53
54
55
56
57
58
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds